Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway Improves Response of Long-Term Estrogen-Deprived Breast Cancer Xenografts to Antiestrogens

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2466
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Practicalities of Drugging the Phosphatidylinositol-3-Kinase/Akt Cell Survival Signaling Pathway

Clinical Cancer Research
Cancer ResearchOncology
2006English

Phosphatidylinositol-3-Kinase Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2004English

New Role for SHC in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/Akt Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2012English

Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Correction: Article on Phosphatidylinositol 3-Kinase in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Hypoxia Induces the Activation of the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway in PC12 Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy